Control and Measurement of Plasma pH in Equilibrium Dialysis: Influence on Drug Plasma Protein Binding
Open Access
- 23 November 2010
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 39 (3), 551-557
- https://doi.org/10.1124/dmd.110.036988
Abstract
Past publications have highlighted the influence of postdialysis plasma pH on the measured fraction unbound in plasma (fup). There is disparity in the industry as to which of two main methods is more suitable for controlling postdialysis plasma pH: the use of either a stronger buffer or a CO2 atmosphere for the incubation. In the current study, it has been found that 10% CO2 could be too high for the buffering capacities of both 100 mM sodium phosphate (pH 7.40 decreased to pH 6.90 after a 6-h incubation) and plasma (decreased below pH 7.40 after a 6-h incubation). To provide appropriate control over the postdialysis plasma pH, for a range of species, it is proposed that a standard phosphate buffer strength (100 mM) and pH (7.40) in combination with a 5% CO2 atmosphere be used for equilibrium dialysis. Furthermore, statistically significant differences in fup values obtained with a pH difference of less than 0.32 pH unit have been demonstrated. An acceptance range for postdialysis plasma pH in routine in vitro fup screening assays of pH 7.40 ± 0.10 is recommended.Keywords
This publication has 28 references indexed in Scilit:
- Plasma Protein Binding in Drug Discovery and DevelopmentCombinatorial Chemistry & High Throughput Screening, 2010
- Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposureXenobiotica, 2009
- Updates on Contemporary Protein Binding TechniquesDrug Metabolism and Pharmacokinetics, 2009
- Plasma / Serum Protein Binding DeterminationsCurrent Drug Metabolism, 2008
- The pH Dependency of the Binding of Drugs to Plasma Proteins in ManTherapeutic Drug Monitoring, 2005
- Shift in pH of biological fluids during storage and processing: effect on bioanalysisJournal of Pharmaceutical and Biomedical Analysis, 2003
- Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein bindingJournal of Pharmaceutical Sciences, 2003
- Changes in plasma protein binding have little clinical relevanceClinical Pharmacology & Therapeutics, 2002
- Cheminformatic Models To Predict Binding Affinities to Human Serum AlbuminJournal of Medicinal Chemistry, 2001
- Factors Influencing the Apparent Protein Binding of QuinidineJournal of Pharmaceutical Sciences, 1982